Appliance Powder Coatings Market worth $6.93 billion in 2031 - Exclusive Report by MarketsandMarkets™
Source: PR Newswire
The global appliance powder coatings market is projected to expand from $4.63 billion in 2026 to $6.93 billion by 2031, representing an 8.42% CAGR. Growth is attributed to higher appliance production, demand for durable and aesthetic finishes, and adoption of low-VOC, solvent-free and energy-efficient coating systems. Asia-Pacific held 63.9% of market value in 2025, while Europe ranked second; leading suppliers include Akzo Nobel, PPG, Sherwin-Williams and Axalta.
Analysis
This is not a near-term earnings catalyst: appliance powder is a narrow end-market within diversified coatings portfolios, and the underlying forecast is vendor-sponsored rather than independently demand-validated. The investable signal is directional: low-temperature and higher-performance formulations can improve customer retention and mix, but incremental pricing must exceed the added resin/R&D cost to matter for consolidated margins. AXTA, PPG, and AKZA have the clearest technology fit; their relative upside is more likely to emerge through mix and share gains than a material step-up in aggregate volumes.
The more consequential second-order effect is on appliance OEM capex. Faster-curing systems lower energy intensity and line cycle times, making conversion economical only when factories are being upgraded or built. That favors suppliers with local technical service and Asia-Pacific manufacturing footprints, while smaller regional players could pressure price in standard grades. For PPG and AKZA, a sustained shift toward differentiated formulations supports modest multiple resilience; for AXTA, its lower direct appliance exposure means this is insufficient to alter the core refinish/industrial earnings debate.
Over 1-3 months, monitor quarterly commentary from Whirlpool (WHR), Electrolux (ELUXY), Haier Smart Home (600690 CH), and Midea (000333 CH) on appliance output, factory utilization, and procurement inflation. Over 6-18 months, the thesis strengthens only if coating companies show powder volume growth above industrial production and explicit gross-margin accretion. It is falsified by OEM destocking, weak Asian appliance exports, or raw-material inflation that cannot be passed through; absent those confirmations, broad coatings valuations should not re-rate on this release.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.38
Ticker Sentiment
Key Decisions for Investors
- No standalone trade on the release; treat it as a watch signal rather than an earnings-changing catalyst given the low assessed impact and unverified market-study inputs.
- Prefer a 6-12 month relative long AKZA / short SHW basket, sized modestly: AKZA has greater exposure to European sustainability-driven industrial conversion, while SHW's earnings sensitivity remains more tied to North American architectural demand. Exit if AKZA's industrial/powder mix fails to outgrow sales for two quarters or European manufacturing PMIs deteriorate materially.
- Add PPG only on evidence of powder-coatings volume outperformance or margin expansion in the next two earnings prints; target a 5-8% relative return versus the S&P 500 over 6 months, with a 3-4% relative stop if industrial volumes weaken or guidance flags OEM pricing pressure.
- Use AXTA as an M&A/technology-screen alert, not a powder-coatings long: investigate acquisitions or commercial wins in low-temperature industrial powder. A confirmed deal at a disciplined valuation could create upside, but appliance exposure alone does not offset AXTA's larger auto-refinish cycle risk.
More News
- Next week brings major risks for the stock market, just as the AI trade keeps faltering
- What next for France as riots rattle markets? Three questions facing investors ahead of more protests
- Looters hit 3,000 French businesses. Within hours, the haul was trending on Vinted under the riot’s date
- Kinder Morgan, Energy Transfer and Williams could benefit from cheap natural gas
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Palantir (PLTR) Q4 2025 Earnings: 70% Revenue Growth, Then an 11% Single-Day Crash
- AlphaSense Pricing: What Public Contract Data Shows in 2026